As of 2026-03-17, the Relative Valuation of Teladoc Health Inc (TDOC) is (21.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.39 USD, the upside of Teladoc Health Inc based on Relative Valuation is -503.1%.
The range of the Relative Valuation is (19.67) - (20.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 24.0x | 21.4x |
| Forward P/E multiples | 16.8x - 18.7x | 17.4x |
| Fair Price | (19.67) - (20.95) | (21.73) |
| Upside | -465.0% - -488.7% | -503.1% |
| Date | P/E |
| 2026-03-16 | -4.86 |
| 2026-03-13 | -4.78 |
| 2026-03-12 | -4.77 |
| 2026-03-11 | -4.87 |
| 2026-03-10 | -4.96 |
| 2026-03-09 | -4.72 |
| 2026-03-06 | -4.52 |
| 2026-03-05 | -4.56 |
| 2026-03-04 | -4.57 |
| 2026-03-03 | -4.54 |
| 2026-03-02 | -4.60 |
| 2026-02-27 | -4.68 |
| 2026-02-26 | -4.76 |
| 2026-02-25 | -4.14 |
| 2026-02-24 | -4.04 |
| 2026-02-23 | -4.06 |
| 2026-02-20 | -4.22 |
| 2026-02-19 | -4.35 |
| 2026-02-18 | -4.15 |
| 2026-02-17 | -4.06 |
| 2026-02-13 | -4.14 |
| 2026-02-12 | -3.98 |
| 2026-02-11 | -4.17 |
| 2026-02-10 | -4.32 |
| 2026-02-09 | -4.44 |
| 2026-02-06 | -4.46 |
| 2026-02-05 | -4.21 |
| 2026-02-04 | -4.37 |
| 2026-02-03 | -4.55 |
| 2026-02-02 | -4.78 |
| 2026-01-30 | -4.85 |
| 2026-01-29 | -5.08 |
| 2026-01-28 | -5.11 |
| 2026-01-27 | -5.26 |
| 2026-01-26 | -5.60 |
| 2026-01-23 | -5.64 |
| 2026-01-22 | -5.66 |
| 2026-01-21 | -5.49 |
| 2026-01-20 | -5.41 |
| 2026-01-16 | -5.59 |
| 2026-01-15 | -5.82 |
| 2026-01-14 | -5.89 |
| 2026-01-13 | -6.23 |
| 2026-01-12 | -6.46 |
| 2026-01-09 | -6.64 |
| 2026-01-08 | -6.78 |
| 2026-01-07 | -6.74 |
| 2026-01-06 | -7.12 |
| 2026-01-05 | -6.48 |
| 2026-01-02 | -6.28 |